Chris Lee, VP, Global Regulatory Affairs and Quality Management, Merck & Co., explains how the TCS ADD platform enables fast regulatory action and rapid rollout of new drugs.
TCS partnered with Merck to drive innovation within the pharma enterprise and streamline its business processes using digital applications and solutions.
An innovation council comprising experts from Merck and TCS’ ADD team launched many industry-first initiatives. These include the creation of a unique, smart mobile app and an executive dashboard that offers complete visibility into the regulatory submission process, for any product.
For Merck, the app and dashboard reduced the time taken to respond to regulatory queries. The platform also increased operational efficiency, accelerated drug development, reduced the time-to-market, and helped plan subsequent activities within the time frame.
Merck and TCS leveraged their core industrial strength as well as technology and subject matter expertise to create solutions that drive global pharma adoption and increase usage.